1. Home
  2. HROW vs EFC Comparison

HROW vs EFC Comparison

Compare HROW & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$34.10

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

EFC

Ellington Financial Inc.

HOLD

Current Price

$11.80

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
EFC
Founded
1998
2007
Country
United States
United States
Employees
N/A
400
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HROW
EFC
Price
$34.10
$11.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$71.14
$14.55
AVG Volume (30 Days)
924.6K
1.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
13.09%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$44.68
N/A
Revenue Next Year
$40.71
$52.40
P/E Ratio
N/A
$9.50
Revenue Growth
N/A
N/A
52 Week Low
$20.85
$11.12
52 Week High
$54.98
$14.12

Technical Indicators

Market Signals
Indicator
HROW
EFC
Relative Strength Index (RSI) 27.80 26.02
Support Level $30.55 N/A
Resistance Level $40.64 $14.00
Average True Range (ATR) 2.54 0.27
MACD -1.45 -0.02
Stochastic Oscillator 2.31 18.50

Price Performance

Historical Comparison
HROW
EFC

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: